LEADER 01902cam2-2200565---450- 001 990000034400203316 005 20050810082604.0 010 $a1-873403-03-8 035 $a0003440 035 $aUSA010003440 035 $a(ALEPH)000003440USA01 035 $a0003440 100 $a20000914d1992----|||y0itay0103----ba 101 0 $aeng 105 $a||||||||001yy 200 1 $aD.H. Lawrence$ecritical assessments$v8$fedited by David Ellis and Ornella De Zorzo 210 $aMountfield$cHelm information$dc1992 215 $a4 v.$c4 ritr. 461 1$10010097550$12001$a<> Helm Information critical assessment of writers in English 606 $aCritica letteraria inglese 610 6 $aScrittori inglesi 676 $a820. 9 702 1$aCLARKE,$bGraham 702 1$aDE ZORDO,$bOrnella 702 1$aELLIS,$bDavid 801 $aIT$bSALBC$gISBD 912 $a990000034400203316 951 $aVII.3.B. 1653/1(II na 820 CRI 8 / 1)$b148478 L.M.$cII na 820 951 $aVII.3.B. 1653/2(II na 820 CRI 8 / 2)$b148479 L.M.$cII na 820 951 $aVII.3.B. 1653/3(II na 820 CRI 8 / 3)$b148480 L.M.$cII na 820 951 $aVII.3.B. 1653/4(II na 820 CRI 8 / 4)$b148481 L.M.$cII na 820 959 $aBK 969 $aUMA 979 $c20000914$lUSA01$h1716 979 $c20001019$lUSA01$h1054 979 $c20001019$lUSA01$h1451 979 $c20001019$lUSA01$h1459 979 $c20001019$lUSA01$h1536 979 $c20001024$lUSA01$h1512 979 $c20001027$lUSA01$h1517 979 $c20001027$lUSA01$h1521 979 $c20001110$lUSA01$h1708 979 $c20001124$lUSA01$h1206 979 $aPATTY$b90$c20020222$lUSA01$h0944 979 $aPATTY$b90$c20020222$lUSA01$h1021 979 $c20020403$lUSA01$h1611 979 $aPATRY$b90$c20040406$lUSA01$h1604 979 $aCOPAT3$b90$c20050810$lUSA01$h0826 996 $aD.H. LAWRENCE$9529449 997 $aUNISA LEADER 02688nam 2200565Ia 450 001 996320223303316 005 20230721015959.0 010 $a1-282-69713-7 010 $a9786612697135 010 $a92-4-068512-X 035 $a(CKB)2670000000033540 035 $a(EBL)557633 035 $a(OCoLC)650859957 035 $a(SSID)ssj0000419097 035 $a(PQKBManifestationID)11251989 035 $a(PQKBTitleCode)TC0000419097 035 $a(PQKBWorkID)10378119 035 $a(PQKB)10421859 035 $a(MiAaPQ)EBC557633 035 $a(Au-PeEL)EBL557633 035 $a(CaPaEBR)ebr10404019 035 $a(CaONFJC)MIL269713 035 $a(EXLCZ)992670000000033540 100 $a20090102d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aGuidelines for the psychosocially assisted pharmacological treatment of opioid dependence$b[electronic resource] 210 $aGeneva, Switzerland $cWorld Health Organization$d2009 215 $a1 online resource (132 p.) 300 $aDescription based upon print version of record. 311 $a92-4-154754-5 320 $aIncludes bibliographical references (p. 96-111). 327 $aCOVER; TITLE; COPYRIGHT; Contents; Acknowledgements; Abbreviations and acronyms; Executive summary; Summary of recommendations; 1 Scope and purpose; 2 Method of formulating recommendations; 3 Background; 4 Guidelines for health systems at national and subnational levels; 5 Programme level guidelines - for programme managers and clinical leaders; 6 Patient level guidelines - for clinicians; AnnexES 330 $aThese Guidelinesreview the use of medicines such as methadone, buprenorphine, naltrexone and clonidine in combination with psychosocial support in the treatment of people dependent on heroin or other opioids. Based on systematic reviews of the literature and using the GRADE approach to determining evidence quality, the guidelines contain specific recommendations on the range of issues faced in organizing treatment systems, managing treatment programmes and in treating people dependent on opioids. Developed in collaboration with internationally acclaimed experts from the different regions of th 606 $aOpioid abuse 606 $aDrug abuse 615 0$aOpioid abuse. 615 0$aDrug abuse. 676 $a616.8632061 712 02$aWorld Health Organization. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a996320223303316 996 $aGuidelines for the psychosocially assisted pharmacological treatment of opioid dependence$92064785 997 $aUNISA